HR Q2 2026 Earnings Call Summary | Stock Taper
Logo
HR

HR — Healthcare Realty Trust Incorporated

NYSE


Q2 2026 Earnings Call Summary

July 31, 2026

Summary of Healthcare Realty Q2 2026 Earnings Call

1. Key Financial Results and Metrics

  • Normalized FFO per share: $0.41
  • Same store cash NOI growth: 5.1%
  • FAD per share: $0.32, with a quarterly dividend payout ratio of 76%.
  • Same store occupancy: Increased to nearly 93%, with tenant retention at 88.5%.
  • Cash leasing spreads: Averaged 4.8% for the quarter.
  • Leverage: Reduced by nearly a full turn, maintaining mid-5x range.
  • Capital raised: $1.1 billion through convertible bonds and delayed draw term loans, with a blended interest rate of approximately 4%.

2. Strategic Updates and Business Highlights

  • The company is one year into its strategic plan, achieving or exceeding all key objectives, including a 5.7% average same store NOI growth over the past year.
  • Leasing success: Executed 3.5 million square feet of leases year-to-date, improving the weighted average remaining lease term to 65 months.
  • Significant transactions with health systems, including:
    • CommonSpirit: Renewed 160,000 square feet and sold 15 acres of land for $16 million.
    • Wellstar: Renewed 215,000 square feet and sold the Kennestone Cancer Center for $36 million.
    • Ascension St. Thomas: Executed a letter of intent for 203,000 square feet with a positive cash leasing spread of 11%.
  • Capital allocation: Focus on redevelopments, joint venture acquisitions, and managing the balance sheet, with $200 million in acquisitions planned through a partnership with KKR.

3. Forward Guidance and Outlook

  • Increased full-year normalized FFO per share guidance by $0.02 to a midpoint of $1.64, with an upper range of $1.66.
  • Same store cash NOI growth outlook raised to 4.25% to 5%.
  • The company expects continued strong leasing momentum and high tenant retention, with a robust pipeline of over 3 million square feet.

4. Bad News, Challenges, or Points of Concern

  • Potential deceleration: While the company has performed well, there is an acknowledgment that the absorption benefits seen in the first half of the year may fade, impacting future growth.
  • Market pressures: The company is aware of the need to maintain earnings growth in a higher interest rate environment, which could challenge the historical norms of medical office growth.
  • Leverage concerns: Although leverage is down, the company must remain vigilant about managing debt and capital allocation effectively.

5. Notable Q&A Insights

  • Future earnings guidance: Management expressed confidence in exceeding the previously set earnings targets, driven by strong operational performance and capital allocation strategies.
  • Joint venture dynamics: The partnership with KKR is seen as a growth vehicle, with the company focusing on capital recycling and disciplined acquisitions.
  • Tenant improvements: There is a focus on reducing tenant improvement costs, which have been trending down, benefiting from higher retention and occupancy rates.
  • Market conditions: The company has not seen a significant impact on cap rates despite rising interest rates, maintaining a competitive advantage in the transaction market.

Overall, Healthcare Realty reported strong operational performance in Q2 2026, with positive growth metrics and strategic advancements, while also highlighting potential challenges in sustaining growth in a changing market environment.